High proliferation by the MCL35 assay is associated with inferior outcomes in patients treated with intensive regimens – a correlative study from the Alliance 50403 trial.
   Google Scholar   
Citation:
Hematol Oncol vol 35 (suppl S2) 152-2
Meeting Instance:
ICML 2017
Year:
2017
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3168  
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
Lymphoma    
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                         
Networks:
11030, CA136, COLUMBUS, LAPS-MN026, NY018   
Study
CALGB-50403
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: